Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 11, 1999

View Archived Issues

Urologix's Targis System superior to alpha-blockers in BPH therapy

ADCON-L improves clinical outcome following lumbar discectomy

Pacific Pharmaceuticals acquires Binary Therapeutics

DTaP-IPV vaccine receives marketing authorization in Germany

ID Biomedical and Ribi ImmunoChem to develop E. coli vaccine

RPR and Targacept enter agreement to develop AD and PD treatments

Sunrise LTK System PMA accepted for filing by FDA

ICAgen obtains patent and exclusive rights to ion channel technology

Platinum-based chemotherapy for ovarian cancer increases risk of leukemia

Bristol-Myers Squibb and EntreMed modify research agreement

Roberts enriches product pipeline with addition of RL-0903

Patient enrollment completed in loteprednol/antibiotic combination study

Shaman changes direction; new focus is on botanicals

OT-7100, a novel analgesic compound for the treatment of peripheral neuropathic pain

Potassium channel modulators claimed for dementia by Bayer

New polycarboxamides with multiple pharmacological actions developed at Pharmacia & Upjohn

Zeneca patents new class of DNA gyrase-inhibiting antibiotics

Antiinflammatory/immunosuppressant agents acting on p38 MAP kinase designed at Novartis

TNP-470 inhibits human lung tumor growth and neovascularization

Isotechnika's novel atomic substitution technology yields improved calcium channel blocker

Renal toxicity of NS-718 and amphotericin B compared in laboratory and animal studies

Aronex further defines mechanism of action of AR-177

In vitro and in vivo profile of antifungal activity reported for FK-463

BCH-10652: structure and first clinical data presented at AIDS conference

Facilitated DNA plasmid vaccine construct induces immune responses in HIV+ subjects

Genentech to withdraw support from pimagedine development

Sarawak MediChem's calanolide compounds featured at ROI conference

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...